![Mark J. Tebbe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark J. Tebbe
Directeur Technique/Scientifique/R&D chez
Newco (Canada)
Profil
Mark is CTO of Matchpoint Therapeutics.
Formerly Mark was Co-Founder and CTO of Quench Bio and before that was VP, Head of Drug Discovery at Quartet Medicine.
Mark has >23 years of experience in drug discovery and development and is a co-inventor of Incivek (Telaprevir), an HCV protease inhibitor.
He was previously VP of Medicinal and Computational Chemistry at Forma Therapeutics where he focused on small molecule cancer therapeutics.
Prior to that, Mark held positions of increasing responsibility during his 16-year career at Eli Lilly including head of chemistry and Global Head of Operations for the discovery chemistry group.
He obtained his Ph.D.
in organic chemistry from Stanford University and his undergraduate degree from the University of Notre Dame.
Postes actifs de Mark J. Tebbe
| Sociétés | Poste | Début |
|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 01/11/2017 |
Newco (Canada)
 Newco (Canada) Investment ManagersFinance Provides investment services | Directeur Technique/Scientifique/R&D | 01/06/2023 |
Anciens postes connus de Mark J. Tebbe
| Sociétés | Poste | Fin |
|---|---|---|
Matchpoint Therapeutics, Inc.
 Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Directeur Technique/Scientifique/R&D | 01/03/2023 |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Président | 01/12/2019 |
ELI Lilly Leasing Ltd.
 ELI Lilly Leasing Ltd. Financial ConglomeratesFinance Operates as a dormant company | Consultant / Advisor | 01/06/2010 |
Quench Bio, Inc.
 Quench Bio, Inc. BiotechnologyHealth Technology Develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases | Fondateur | - |
Quartet Medicine, Inc.
 Quartet Medicine, Inc. BiotechnologyHealth Technology Develops treatments for chronic pain and inflammation | Corporate Officer/Principal | - |
Formation de Mark J. Tebbe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
ELI Lilly Leasing Ltd.
ELI Lilly Leasing Ltd. Financial ConglomeratesFinance Operates as a dormant company | Finance |
Quartet Medicine, Inc.
Quartet Medicine, Inc. BiotechnologyHealth Technology Develops treatments for chronic pain and inflammation | Health Technology |
Newco (Canada)
Newco (Canada) Investment ManagersFinance Provides investment services | Finance |
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases | Health Technology |
Matchpoint Therapeutics, Inc.
Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Health Technology |
